Global Immunoglobulins Market Research Report 2022

Immunoglobulin’s also called as antibodies are large Y-shaped protein produced by B-cell. These are the glycoprotein molecule produced by plasma cells in response to entry of foreign entity such as bacteria and viruses in the body. Production of antibodies is an important function of immune system. Antibodies use binding mechanism for neutralizing the activity of a foreign particle called as an antigen.
Due to the COVID-19 pandemic, the global Immunoglobulins market size is estimated to be worth US$ 10450 million in 2021 and is forecast to a readjusted size of US$ 13870 million by 2028 with a CAGR of 4.1% during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Immunoglobulins market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Immunoglobulins landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.
IgG accounting for % of the Immunoglobulins global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.
The global major manufacturers of Immunoglobulins include Hualan Biological Engineering Inc., Omrix Biopharmaceuticals Ltd., Behring GmbH, Shanghai RAAS Blood Products, Option Care Enterprises, ADMA Biologics, and BioScrip, etc. In terms of revenue, the global 3 largest players have a % market share of Immunoglobulins in 2021.
This report focuses on Immunoglobulins volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Immunoglobulins market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.
Global Immunoglobulins Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2017 to 2028. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
IgG
IgA
IgM
IgE
IgD
Segment by Application
Hospital
Research
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
By Company
Hualan Biological Engineering Inc.
Omrix Biopharmaceuticals Ltd.
Behring GmbH
Shanghai RAAS Blood Products
Option Care Enterprises
ADMA Biologics,
BioScrip